Tuesday, November 24, 2020
Home Tags Hematology

Tag: Hematology

New data at ASH to reinforce breadth of Novartis hematology portfolio...

Pivotal ASCEMBL study of novel, investigational STAMP inhibitor asciminib (ABL001) vs. bosutinib in CML patients previously treated with two or more TKIsELARA results for...

Schrödinger to Present Data from Its MALT1 Inhibitor Program at the...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and...

Karyopharm Announces XPOVIO® (Selinexor) Clinical Data to be Presented at the...

NEWTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that twenty-one abstracts...

Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency...

Dear editor, Congenital factor X (FX) deficiency...

CAR T Cells Push Forward in Solid Tumors Following Positive Results...

Prasad S. Adusumilli, MD, FACS Chimeric antigen receptor (CAR) T-cell therapy continues to evolve through research for the treatment of patients with hematologic malignancies. In...

City of Hope appoints chair of hematology and hematopoietic cell transplantation

  Eileen Smith   Stephen J. Forman Eileen Smith, MD, has been appointed chair of the department of hematology and hematopoietic cell transplantation...

Hematology Experts Review Impactful Data from 2019 ASH Annual Meeting

With over 25,000 hematology professionals in attendance, over 3,000 abstracts were shared in oral and poster presentations at the 61st American Society of Hematology (ASH)...

Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And...

  THOUSAND OAKS, Calif., Dec. 10, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced additional results from the primary analysis of the Phase 3 CANDOR study evaluating...

Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in...

INDIANAPOLIS, Dec. 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)...

November 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2019. This roundup includes...
20,764FansLike
2,452FollowersFollow
16,600SubscribersSubscribe

EDITOR PICKS